Diagnamed Holdings Corp. (DMED.CN)
CAD 0.03
(0.0%)
CAD 0.03
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -1.17 Million CAD | -3.4% |
| 2022 | -1.13 Million CAD | -296.21% |
| 2021 | 580.48 Thousand CAD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -270.57 Thousand CAD | -74.39% |
| 2024 Q3 | -167.04 Thousand CAD | 38.26% |
| 2024 Q1 | -155.15 Thousand CAD | 5.47% |
| 2023 FY | -1.25 Million CAD | -10.01% |
| 2023 Q4 | -164.13 Thousand CAD | 29.0% |
| 2023 Q3 | -231.16 Thousand CAD | 50.04% |
| 2023 Q2 | -462.69 Thousand CAD | -26.96% |
| 2023 Q1 | -364.43 Thousand CAD | -18.33% |
| 2022 FY | -1.13 Million CAD | -296.21% |
| 2022 Q3 | -328.8 Thousand CAD | -0.8% |
| 2022 Q2 | -326.18 Thousand CAD | -88.82% |
| 2022 Q4 | -307.97 Thousand CAD | 6.34% |
| 2022 Q1 | -172.74 Thousand CAD | 15.14% |
| 2021 Q1 | -69.29 Thousand CAD | 0.0% |
| 2021 Q4 | -203.56 Thousand CAD | 40.4% |
| 2021 Q3 | -341.52 Thousand CAD | -392.88% |
| 2021 Q2 | -69.29 Thousand CAD | 0.0% |
| 2021 FY | 580.48 Thousand CAD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| AI/ML Innovations Inc. | -1.66 Million CAD | 29.265% |
| Pangenomic Health Inc. | -2.71 Million CAD | 56.572% |
| nDatalyze Corp. | -316.56 Thousand CAD | -272.019% |
| Treatment.Com International Inc. | -2.32 Million CAD | 49.39% |
| Unidoc Health Corp. | -2.2 Million CAD | 46.485% |